Alloreactive cytotoxic T lymphocytes focus on specific major histocompatibility complex-bound peptides

Area of Science:

• Immunology
• Molecular Biology
• Transplantation Science

Background:

• Alloreactive T cells are crucial in transplant rejection and autoimmune diseases.
• Their recognition of allogeneic major histocompatibility complex (MHC) molecules can be peptide-dependent or independent.
• Understanding this recognition mechanism is key to improving transplant outcomes.

Purpose of the Study:

• To investigate the peptide specificity of anti-HLA-B7 alloreactive cytotoxic T lymphocyte (CTL) clones.
• To determine if CTL allorecognition is peptide-specific, even in the context of peptide-independent stimulation protocols or antigen-processing deficient cells.

Main Methods:

• Generated and characterized 12 anti-HLA-B7 alloreactive CTL clones.
• Tested recognition of mutated HLA-B7 molecules and eluted peptides using high-performance liquid chromatography (HPLC).
• Assessed recognition of synthetic peptides and allogeneic cells, including antigen-processing deficient T2 cells.

Main Results:

• All 12 CTL clones recognized point mutations within the HLA-B7 peptide-binding groove.
• Eleven of 12 CTL clones recognized specific peptides eluted from HLA-B7.
• No CTL clones promiscuously recognized multiple synthetic peptides, indicating fine peptide specificity.

Conclusions:

• Cytotoxic T lymphocyte (CTL) allorecognition of allogeneic major histocompatibility complex (MHC) molecules is predominantly peptide-specific.
• This peptide specificity is maintained even when MHC molecules are presented by antigen-processing deficient cells.
• The findings challenge the notion of widespread peptide-independent CTL allorecognition.